US EditionRaymond James Financial Inc. Boosts Position in Madrigal Pharmaceuticals, Inc. $MDGL
Summary by americanbankingnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Raymond James Financial Inc. Boosts Position in Madrigal Pharmaceuticals, Inc. $MDGL
Raymond James Financial Inc. boosted its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 0.1% in the first quarter, Holdings Channel reports. The fund owned 53,916 shares of the biopharmaceutical company’s stock after purchasing an additional 70 shares during the quarter. Raymond James Financial Inc.’s holdings in Madrigal Pharmaceuticals were worth […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
